Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†
- Study type
- Clinical guideline
- Study name
- ESMO Fertility Preservation 2020
- Design
- Clinical guideline (ESMO Clinical Practice Guidelines) prepared by the ESMO Guidelines Committee
- Source
- Annals of Oncology · 2020
In plain words
This guideline from the European Society for Medical Oncology (ESMO) is about preserving fertility in people with cancer who have gone through puberty. It also covers pregnancy after cancer treatment has ended. If you would like to have children in the future, talk to your oncologist about this before starting treatment.
Study population
Post-pubertal patients with cancer, based on the title of the guideline. No further details are available in the PubMed record; they should be checked in the full text of the guideline.
Endpoints
The PubMed record has no abstract. Based on the title, the subject of the guideline is fertility preservation and post-treatment pregnancy in post-pubertal cancer patients.
Safety and side effects
No information is available in the PubMed record. For safety considerations, consult the full text of the guideline.
Clinical significance and place in guidelines
This document is an ESMO clinical guideline published in 2020. Because the PubMed record does not include an abstract or the text of the recommendations, the exact content of the recommendations and the levels of evidence must be extracted from the full text of the guideline. Whether the guideline is still current should also be checked.
Limitations
This card is based only on the bibliographic information of the PubMed record (no abstract). Recommendations and levels of evidence should be added after reading the full text of the guideline and confirmation by an oncologist.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.